Barbara McGovern MD
Dr. Barbara McGovern is Vice President of Medical Affairs at Seres Therapeutics. She obtained her M.D. degree from the Albert Einstein College of Medicine and did her residency and infectious disease training at Tufts Medical Center where she worked many years as an infectious disease specialist. Dr. McGovern’s early clinical career involved working with HIV-infected patients, including the care of incarcerated women with HIV and hepatitis C co-infection. When the rates of morbidity and mortality from HIV declined on potent antiretroviral therapy, she was one of the first to observe that end-stage liver disease secondary to hepatitis C infection had become a leading cause of death in HIV-infected patients and subsequently devoted her clinical research career to the management of these patients. Since 2012 she has been working within the pharmaceutical arena and currently is head of Medical Affairs at Seres Therapeutics, which is developing microbiome-based therapies.